Status:

COMPLETED

Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets

Lead Sponsor:

MonoSol Rx

Conditions:

Nausea and Vomiting, Postoperative

Nausea With Vomiting Chemotherapy-Induced

Eligibility:

All Genders

18-45 years

Phase:

PHASE1

PHASE2

Brief Summary

This was an open-label, balanced, two-treatment, two-period, randomized sequence crossover bioequivalence study with a 7-day washout between periods. Each treatment was administered after an overnight...

Detailed Description

This was an open label, balanced, randomized, two-treatment, two-period, randomized sequence crossover study conducted in healthy adult male and female volunteers. Subjects checked into the study cent...

Eligibility Criteria

Inclusion

  • Volunteer should have written informed consent.
  • Volunteer healthy adult within 18-45 years of age (inclusive).
  • Body mass index of 18.5 kg/m\^2 and 25 kg/m\^2, body weight not less than 50 kg.
  • Volunteer must be of normal health.
  • Volunteer should have a normal ECG, chest X-ray and vital signs.
  • If study volunteer is a female and is of child bearing potential practicing an acceptable method of birth control for the duration of the study.
  • Criteria:

Exclusion

  • Volunteer doesn't understand the informed consent.
  • Volunteer with a history of hypersensitivity or idiosyncratic reaction to study drug or any other related drug.
  • Volunteer having any evidence of impairment of renal, hepatic, cardiac, lung or gastrointestinal function, by standard laboratory, imaging or monitoring procedures
  • Volunteer who smokes regularly, alcohol or drug abuse
  • Volunteer who has taken over the counter or prescribed medications
  • Volunteer with clinically significant abnormal values of laboratory parameters.
  • Volunteer who has participated in any other clinical investigation using experimental drug or had bled more than 350 mL in the past 3 months.
  • Female volunteer demonstrating a positive pregnancy screen with urine pregnancy test (strip method).

Key Trial Info

Start Date :

September 16 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 6 2008

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT01217190

Start Date

September 16 2008

End Date

October 6 2008

Last Update

July 29 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VIMTA VHS Research Centre

Adyār, Chennai, India, 600 113